BioStem Technologies, Inc.
BSEM
$15.00
$0.473.24%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.74M | 5.18M | 4.44M | -2.74M | -1.60M |
| Total Depreciation and Amortization | 99.30K | 50.90K | 53.70K | 54.60K | 56.00K |
| Total Amortization of Deferred Charges | 153.10K | 25.90K | 32.00K | 166.30K | 50.90K |
| Total Other Non-Cash Items | -2.37M | 4.73M | 3.28M | 1.84M | 1.40M |
| Change in Net Operating Assets | 4.83M | -3.68M | -7.25M | -731.50K | -290.10K |
| Cash from Operations | 9.46M | 6.30M | 558.10K | -1.41M | -390.90K |
| Capital Expenditure | -122.80K | -160.00K | -12.40K | 0.00 | -96.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -105.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.25M | -- | -- | 105.00K | 0.00 |
| Cash from Investing | -1.37M | -160.00K | -12.40K | 0.00 | -96.30K |
| Total Debt Issued | -- | -- | -- | 60.90K | 488.50K |
| Total Debt Repaid | -143.50K | -212.50K | -391.80K | -455.20K | -285.60K |
| Issuance of Common Stock | 100.00K | 0.00 | 250.00K | 1.94M | 70.50K |
| Repurchase of Common Stock | 0.00 | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.50K | -212.50K | -141.80K | 1.54M | 273.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 8.04M | 5.93M | 403.80K | 129.50K | -213.90K |